|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 117.20 PLN | -0.85% |
|
-1.35% | -13.95% |
| 05-27 | Scope Fluidics says Bacteromic granted U.S. patent 'microfluidic chip' | RE |
| 05-15 | Scope Fluidics Q1 net loss at 13.5 million zlotys | RE |
Main competitors
| Consensus | Analysts' target price evolution (4 months) | Analysts' recommendations evolution (4 months) | Financial estimates divergence | Analysts' Target price divergence | Average Target P. | Objective/dr gap | Nbr of analysts | ||
|---|---|---|---|---|---|---|---|---|---|
 | - | - | 198.2 | +67.68% | 1 | ||||
| 56.55 | +1.68% | 11 | ||||||
| 22.29 | -1.13% | 7 | ||||||
| 8.8 | +79.59% | 10 | ||||||
| - | - | 48.3 | +28.32% | 1 | ||||
| 35.4 | -2.64% | 5 | ||||||
| 5.9 | -11.81% | 5 | ||||||
| - | 44,500 | +57.8% | 2 | |||||
| 8.333 | +77.3% | 3 | ||||||
| Average | 4,987.08 | +32.98% | 5 | ||||||
| Weighted average by Cap. | 2,413.69 | +17.75% | 7 |
- Stock Market
- Stocks
- SCP Stock
- Sector Scope Fluidics S.A.
- Sector consensus
Select your edition
All financial news and data tailored to specific country editions
